In the replication study MCC-Spain, the OR for CRC did not show a positive trend, although the highest risk was found in the highest FliC quartile (Q4 vs Q1, OR: 1.14, 95% CI: 0.81–1.59).
← all excerpts
Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer.
2
—
—
The sentences
We found a significant trend for higher antibody responses to FliC in CRC cases compared to controls in the Nijmegen/Detroit study, which could not be reproduced in the replication study MCC-Spain.